Perigon Wealth Management LLC Grows Stock Holdings in CVS Health Corporation $CVS

Perigon Wealth Management LLC grew its stake in shares of CVS Health Corporation (NYSE:CVS) by 126.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 33,853 shares of the pharmacy operator’s stock after acquiring an additional 18,872 shares during the period. Perigon Wealth Management LLC’s holdings in CVS Health were worth $2,552,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of CVS. Thompson Investment Management Inc. raised its holdings in CVS Health by 1.8% during the third quarter. Thompson Investment Management Inc. now owns 127,669 shares of the pharmacy operator’s stock worth $9,625,000 after purchasing an additional 2,297 shares during the last quarter. Mayflower Financial Advisors LLC grew its holdings in CVS Health by 9.4% in the third quarter. Mayflower Financial Advisors LLC now owns 9,331 shares of the pharmacy operator’s stock valued at $703,000 after purchasing an additional 801 shares during the last quarter. FSM Wealth Advisors LLC increased its position in shares of CVS Health by 2.9% in the third quarter. FSM Wealth Advisors LLC now owns 10,203 shares of the pharmacy operator’s stock valued at $769,000 after buying an additional 289 shares in the last quarter. Apella Capital LLC raised its stake in shares of CVS Health by 25.8% during the 3rd quarter. Apella Capital LLC now owns 4,976 shares of the pharmacy operator’s stock worth $405,000 after buying an additional 1,019 shares during the last quarter. Finally, Persium Advisors LLC boosted its position in shares of CVS Health by 6.2% in the 3rd quarter. Persium Advisors LLC now owns 9,571 shares of the pharmacy operator’s stock worth $722,000 after buying an additional 561 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Trading Up 0.4%

Shares of NYSE CVS opened at $79.96 on Tuesday. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The stock’s 50 day moving average price is $78.86 and its two-hundred day moving average price is $73.11. CVS Health Corporation has a 52-week low of $43.65 and a 52-week high of $85.15. The stock has a market capitalization of $101.50 billion, a P/E ratio of 210.41, a PEG ratio of 0.79 and a beta of 0.48.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same period in the previous year, the business earned $1.09 EPS. The business’s quarterly revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have issued reports on CVS. Mizuho lifted their target price on shares of CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. UBS Group reissued an “outperform” rating on shares of CVS Health in a research note on Wednesday, December 10th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Morgan Stanley raised their price target on CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 10th. Finally, Barclays upped their price objective on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, December 10th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $94.67.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.